One of the cellular components of normal wound repair is angiogenesis, the formation of new blood vessels. Wound repair angiogenesis requires activation of fibrinolytic enzymes for cellular migration of microvascular endothelial cells through a fibrin matrix. These fibrinolytic enzymes include the plasminogen activator system, which consists of urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA), balanced by plasminogen activator inhibitor-1 (PAI-1), which limits plasmin generation and excessive fibrinolysis. Mechanisms that regulate plasminogen activators in vivo and the requirement for the plasminogen activator system in wound healing angiogenesis remain undefined. Vitronectin, a glycoprotein found in plasma and deposited at the site of tissue injury, has no defined role in vivo. Vitronectin can bind free PAI-1 , and this complex can bind to the endothelial cell surface receptor for uPA, uPAR. Competition for uPAR determines the balance between fibrinolysis and inhibition. Whereas these regulatory mechanisms have been demonstrated in vitro, the investigators propose to demonstrate that vitronectin modulates the plasminogen activator system in angiogenesis during response to injury. Transgenic mice deficient for vitronectin or the plasminogen activator system gene products appear phenotypically normal. The investigator's preliminary data indicate that in vivo, vitronectin functions as a regulator of fibrinolysis, especially important for endothelial cell migration. The preliminary data also show for the first time that the vitronectin: PAI-1 complex binds growth factors cited to be important for angiogenesis. These data suggest that interaction between vitronectin, the PA system, and growth factors are an important component of endothelial cell response to injury and angiogenesis. The investigator will use a wound healing model in gene-targeted mice deficient in vitronectin, uPA, tPA, or uPAR to define the individual functions for vitronectin and the PA system for neovascularization after tissue injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM057426-04
Application #
6386868
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Ikeda, Richard A
Project Start
1998-06-01
Project End
2003-05-31
Budget Start
2001-06-01
Budget End
2002-05-31
Support Year
4
Fiscal Year
2001
Total Cost
$140,544
Indirect Cost
Name
University of Washington
Department
Surgery
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Busygina, Valeria; Kottemann, Molly C; Scott, Kenneth L et al. (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66:8397-403
Scott, Kenneth L; Plon, Sharon E (2005) CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor. Gene 359:119-26
Scott, Kenneth L; Plon, Sharon E (2003) Loss of Sin3/Rpd3 histone deacetylase restores the DNA damage response in checkpoint-deficient strains of Saccharomyces cerevisiae. Mol Cell Biol 23:4522-31
Tsou, Raymond; Fathke, Carrie; Wilson, Lynne et al. (2002) Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibits wound angiogenesis. Wound Repair Regen 10:222-9
Wilson, Lynne; Fathke, Carrie; Isik, Frank (2002) Tissue dispersion and flow cytometry for the cellular analysis of wound healing. Biotechniques 32:548-51
Tsou, R; Isik, F F (2001) Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 224:81-9
Cole, J; Tsou, R; Wallace, K et al. (2001) Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen 9:77-85
Cole, J; Tsou, R; Wallace, K et al. (2001) Early gene expression profile of human skin to injury using high-density cDNA microarrays. Wound Repair Regen 9:360-70
Jang, Y C; Tsou, R; Gibran, N S et al. (2000) Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 127:696-704
Jang, Y C; Isik, F F; Gibran, N S (2000) Nerve distribution in hemangiomas depends on the proliferative state of the microvasculature. J Surg Res 93:144-8

Showing the most recent 10 out of 12 publications